Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

We evaluated 40 patients undergoing high-dose chemo/radiotherapy (HDCT) and hematopoietic stem cell transplantation (HSCT) (allogeneic (22), autologous (18)) to determine the safety and feasibility of administering low molecular weight heparin (LMWH) as hepatic veno-occlusive disease (VOD) prophylax...

Descripción completa

Detalles Bibliográficos
Autores principales: Forrest, D L, Thompson, K, Dorcas, V G, Couban, S H, Pierce, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2003
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091773/
https://www.ncbi.nlm.nih.gov/pubmed/12796794
http://dx.doi.org/10.1038/sj.bmt.1704087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091773/
https://www.ncbi.nlm.nih.gov/pubmed/12796794
http://dx.doi.org/10.1038/sj.bmt.1704087

Ejemplares similares